About US
Contact us
-
Evonik increases the prices for DEGALAN®, DEGACRYL®, and ROHAGIT®Evonik Industries' Coatings & Additives Business Unit announces a price increase for its entire range of above mentioned trade names by 10%, effective October 1st, 2010 in all regions worldwide.2010/9/8
-
Idenix Pharmaceuticals receives clinical hold order from FDA for IDX184, IDX320 programsIdenix Pharmaceuticals, Inc. (Nasdaq: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that the company r2010/9/8
-
GSK Head of Patient Recruitment Joins Exco InTouchExco InTouch, the leading provider of mobile patient communication solutions for the pharmaceutical and healthcare sectors, announces the new appointment of Director of Patient Recruitment, Judith T2010/9/7
-
FDA approves IDE study to evaluate HeartWare Ventricular Assist SystemHeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart fai2010/9/7
-
Novozymes showcases leading biopharmaceutical solutions at BioProcess International 2010Novozymes Biopharma, part of Novozymes A/S, world leader in bioinnovation, will be showcasing its innovative portfolio of biopharmaceutical technologies and solutions at booth #507 and #509 at the 202010/9/6
-
ACG Worldwide Expands Barrier Film Manufacturing CapacityACG Worldwide is the pioneer of pharmaceutical barrier films for blister packaging and renowned for its barrier packaging solutions in the global pharmaceutical and dietary supplement industries. Th2010/9/6
-
Pfizer to buy FoldRx PharmaPfizer is set to acquire drug discovery and clinical development company FoldRx Pharmaceuticals under an agreement signed between the companies. FoldRx is engaged in clinical and pre-clinical program2010/9/3
-
Merck, Cardiome Pharma receive European approval for BrinavessMerck (known as MSD outside the US and Canada) and Cardiome Pharma's intravenous (IV) formulation of Brinavess (vernakalant) has received marketing approval in the EU, Iceland and Norway. Brinavess2010/9/3
-
pSivida announces FDA Priority Review status for Iluvien NDApSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release back of the eye drug delivery systems for difficult-to-treat conditions, today announced that its licensee, Alim2010/9/2
-
EDIMS licenses First DataBank's National Drug Data File Plus databaseFirst DataBank, a leading provider of drug databases that help drive patient safety, and EDIMS, a leading provider of interoperable emergency department (ED) information management systems, today anno2010/9/2